Difference between revisions of "Cabazitaxel (Jevtana)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replace - "or the prescribing information<ref name="insert"></ref>." to "or the prescribing information.<ref name="insert"></ref>")
(updated content)
Line 2: Line 2:
  
 
==General information==
 
==General information==
Class/mechanism: Taxane, promotes assembly of microtubules, stablizes microtubules, preventing depolymerization, inhibiting interphase/mitosis processes.<ref name="insert">[http://products.sanofi.us/jevtana/jevtana.pdf Cabazitaxel (Jevtana) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/cabazitaxel.pdf Cabazitaxel (Jevtana) package insert (locally hosted backup)]</ref>
+
Class/mechanism: Taxane, promotes assembly of microtubules, stablizes microtubules, preventing depolymerization, inhibiting interphase/mitosis processes.<ref name="insert">[http://products.sanofi.us/jevtana/jevtana.pdf Cabazitaxel (Jevtana) package insert]</ref><ref>[[Media:Cabazitaxel.pdf | Cabazitaxel (Jevtana) package insert (locally hosted backup)]]</ref><ref>[http://www.jevtana.com/ Jevtana manufacturer's website]</ref>
 
<br>Route: IV
 
<br>Route: IV
 
<br>Extravasation: no information
 
<br>Extravasation: no information
  
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>  
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>  
 +
 +
==Diseases for which it is used==
 +
*[[Prostate cancer]]
  
 
==Patient drug information==
 
==Patient drug information==
 
*[http://products.sanofi.us/jevtana/jevtana.pdf#page=5 Cabazitaxel (Jevtana) package insert PDF pages 5-6]<ref name="insert"></ref>
 
*[http://products.sanofi.us/jevtana/jevtana.pdf#page=5 Cabazitaxel (Jevtana) package insert PDF pages 5-6]<ref name="insert"></ref>
 +
*[http://chemocare.com/chemotherapy/drug-info/default.aspx Cabazitaxel (Jevtana) patient drug information (Chemocare)]<ref>[http://chemocare.com/chemotherapy/drug-info/default.aspx Cabazitaxel (Jevtana) patient drug information (Chemocare)]</ref>
 
*[http://www.uptodate.com/contents/cabazitaxel-patient-drug-information Cabazitaxel (Jevtana) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/cabazitaxel-patient-drug-information Cabazitaxel (Jevtana) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/cabazitaxel-patient-drug-information Cabazitaxel (Jevtana) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/cabazitaxel-patient-drug-information Cabazitaxel (Jevtana) patient drug information (UpToDate)]</ref>
  
 
==References==
 
==References==
 
<references/>
 
<references/>
 +
 +
[[Category:Drug index]]
 +
[[Category:Chemotherapy]]
 +
[[Category:Taxanes]]
 +
[[Category:Prostate cancer medications]]

Revision as of 04:12, 8 October 2012

Also known as XRP6258, TXD258, or RPR116258A.

General information

Class/mechanism: Taxane, promotes assembly of microtubules, stablizes microtubules, preventing depolymerization, inhibiting interphase/mitosis processes.[1][2][3]
Route: IV
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Patient drug information

References